BRISTOL MYERS SQUIBB FDA Approval ANDA 060365

ANDA 060365

BRISTOL MYERS SQUIBB

FDA Drug Application

Application #060365

Application Sponsors

ANDA 060365BRISTOL MYERS SQUIBB

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL500MG0NEOMYCIN SULFATENEOMYCIN SULFATE

CDER Filings

BRISTOL MYERS SQUIBB
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 60365
            [companyName] => BRISTOL MYERS SQUIBB
            [docInserts] => ["",""]
            [products] => [{"drugName":"NEOMYCIN SULFATE","activeIngredients":"NEOMYCIN SULFATE","strength":"500MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"NEOMYCIN SULFATE","submission":"NEOMYCIN SULFATE","actionType":"500MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.